Nevertheless, aspartate aminotransferase (AST) and alanine transaminase (ALT) enzymatic activity assays, the liver functional studies demonstrated that TET1 KO substantially alleviated liver damages in the HFD-induced MASLD progression (Fig. 2E,F). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.